Bringing gene therapy to where it's needed
- PMID: 35086771
- DOI: 10.1016/j.molmed.2022.01.005
Bringing gene therapy to where it's needed
Abstract
Gene editing allows the precise modification of cells to correct genetic defects or enhance immunotherapies. A limitation is the delivery of this technology to specific cells or organs. Recently, Banskota et al. reported the use of virus-like particles (VLPs) loaded with gene-editing agents for gene therapy delivery directly inside the body.
Keywords: base editors; gene therapy; in vivo delivery; target specificity.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests No interests are declared.
Comment on
-
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins.Cell. 2022 Jan 20;185(2):250-265.e16. doi: 10.1016/j.cell.2021.12.021. Epub 2022 Jan 11. Cell. 2022. PMID: 35021064 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
